Teleflex Incorporated (TFX) gains 1.23% for July 21

Equities Staff  |

Teleflex Incorporated (NYSE: TFX) shares gained 1.23%, or $4.74 per share, to close Wednesday at $390.89. After opening the day at $390.41, shares of Teleflexorporated fluctuated between $392.00 and $386.65. 299,784 shares traded hands a decrease from their 30 day average of 491,886. Wednesday's activity brought Teleflexorporated’s market cap to $18,267,334,940.

Teleflexorporated is headquartered in Wayne, Pennsylvania..

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. The Company applys purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Its portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.

Visit Teleflex Incorporated’s profile for more information.

About The New York Stock Exchange

The New York Stock Exchange is the world’s largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Teleflex Incorporated and to follow the company’s latest updates, you can visit the company’s profile page here: Teleflex Incorporated’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content